Denis Kourakin

Denis Kourakin is a seasoned entrepreneur and investor with extensive experience in tech, life sciences, and real estate. Currently serving as a Founding Partner at Silicon Valley Catalyst Partners since May 2024, Kourakin has co-founded, invested in, and advised numerous early-stage companies since 2011. Previously, Kourakin held prominent positions such as Executive Partner at Silicon Valley Innovation Center and President and CEO of NGX Bio, where a successful online marketplace for next-generation sequencing services was established, leading to its sale to Admera Health. Kourakin's prior roles include Vice-President at PSN Group, overseeing substantial commercial real estate operations in Russia; Director at Alfa Capital Partners, focused on private equity investments; and Consultant and Associate at The Boston Consulting Group, where strategic projects were developed for major multinational clients. Kourakin began their career as an Auditor at Coopers and Lybrand. Educational credentials include an MBA from Stanford University Graduate School of Business and a BA with distinction in Government and International Relations from Cornell University.